Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans

Journal of Hypertension

Volumn 21, Issue 12, 2003, Pages 2345-2352

  Porteri, Enzo ^a   Rizzoni, Damiano ^a,c   Mulvany, Michael John ^b   De Ciuceis, Carolina ^a   Sleiman, Intissar ^a   Boari, Gianluca E M ^a   Castellano, Maurizio ^a   Muiesan, Maria Lorenza ^a   Zani, Francesca ^a   Rosei, Enrico Agabiti ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b AARHUS UNIVERSITY   (Denmark)

^c SPEDALI CIVILI   (Italy)

Author keywords

Adrenergic system; Hypertrophy; Phaeochromocytoma; Remodeling; Secondary hypertension; Vascular resistance

Indexed keywords

ADRENERGIC SYSTEM; ADULT; ARTERY DIAMETER; ARTERY LESION; ARTICLE; BLOOD VESSEL BIOPSY; CELL STRUCTURE; CELL VOLUME; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYOGRAPHY; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SUBCUTANEOUS FAT; TISSUE REPAIR;

EID: 10744219951     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200312000-00024     Document Type: Article

References (35)

1. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 63:347-504.
2. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HAJ. Microcirculation in hypertension. A new target for treatment? Circulation 2001; 104: 735-740.
3. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61:181-186.
4. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990; 70:921-971.
5. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978; 43:854-864.
6. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual process of remodeling and growth. Hypertension 1993; 21:391-397.
7. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD. Vascular remodeling [Letter]. Hypertension 1996; 28:505-506.
8. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989; 13:968-972.
9. Sterio DC. The unbiased selection of number and sizes of arbitrary particles using the disector. J Microscopy 1984; 134:127-136.
10. Mulvany MJ, Baandrup U, Gundersen HJG. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional disector. Circ Res 1985; 57:794-800.
11. Korsgaard N, Mulvany MJ. Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats. Hypertension 1988; 12:162-167.
12. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS, Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993; 22:523-526.
13. Rizzoni D, Porteri E, Guelfi D, Piccoli A, Castellano M, Pasini G, et al. Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension 2000; 35:931-935.
14. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28:785-790.
15. Nanaki T, Nakayama M, Yamamoto S, Kato R. Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol 1990, 37:30-36.
16. DeBlois D, Schwartz SM, Van Kleef EM, Su JE, Griffin KA, Bidani AK. Chronic alpha-1 adrenergic stimulation increases DNA synthesis in rat arterial wall. Arterioscler Thromb Vasc Biol 1996, 16:1122-1129.
17. Dao HH, Lemay J, De Champlain J, de Blois D, Moreau P. Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent. J Hypertens 2001, 19:1965-1973.
18. 1B-adrenergic receptor in mice. Circulation 2002; 105:1700-1707.
19. O'Callagan CJ, Williams B. The regulation of human vascular smooth muscle extracellular matrix protein production by α-and β-adrenoceptor stimulation. J Hypertens 2002; 20:287-294.
20. Schiffrin EL. Vascular smooth muscle growth and extracellular matrix deposition: is there a role for the sympathetic nervous system? [Editorial]. J Hypertens 2002; 20:179-181.
21. Thybo NK, Mulvany MJ, Jastrup B, Nielsen H, Aalkjaer C. Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertension. J Hypertens 1996; 14:993-998.
22. Intengan HD, Deng LY, Li JS, Schiffrin E. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension 1999; 33(part II):569-574.
23. Beschi M, Castellano M, Agabiti Rosei E, Rizzoni D, Rossini P, Muiesan G. Assessment of semi-automated catecholamine assay by HPLC: choice of reverse-phase C18 or cation-exchange columnns. Chromatographia 1987; 24:455-459.
24. Aalkjaer C, Eiskjaer H, Mulvany MJ, Jespersen B, Kjaer T, Sorensen SS, Pedersen EB. Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. J Hypertens 1989; 7:305-310.
25. Mulvany MJ, Halpern W. Contractile properties of small resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41:19-26.
26. Rizzoni D, Muiesan ML, Porteri E, Salvetti M, Castellano M, Bettoni G, et al. Relations between cardiac and vascular structure in patients with primary and secondary hypertension. J Am Coll Cardiol 1998, 32: 985-992.
27. Baandrup U, Gundersen HJG, Mulvany MJ. It is possible to solve the problem: hypertrophy/hyperplasia of smooth muscle cells in the vessel wall of hypertensive subjects? Prog Appl Microcirc 1985; 8:122-128.
28. Korsgaard N, Christensen KL, Mulvany MJ. Cellular morphology in mesenteric resistance vessels from antihypertensive treated spontaneously hypertensive rats. In Smiths JFM (editor): Pharmacology of cardiac and vascular remodelling. Darmstadt: Steinkopff Verlag; 1991, pp. 33-41.
29. Mulvany MJ. Biophysical aspects of resistance vessels studied in spontaneous and renal hypertensive rats. Acta Physiol Scand 1988; 133(suppl 571):129-138.
30. Muiesan ML, Pasini GF, Salvetti M, Calebich S, Zulli R, Castellano M, et al. Cardiac and vascular structural changes. Prevalence and relation to ambulatory blood pressure in a middle-aged general population in northern Italy: The Vobarno Study. Hypertension 1996; 27:1046-1052.
31. Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti Rosei E. Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 1992, 5:180-186.
32. Rizzoni D, Muiesan ML, Solvetti M, Castellano M, Bettoni G, Monteduro C, et al. The smoothness index, but not the trough to peak ratio predicts changes in carotid artery wall thickness during antihypertensive treatment. J Hypertens 2001, 19:641-647.
33. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al., on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recomendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003, 21:821-848.
34. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Tiberio G, et al. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension 1998, 31(part 2):335-341.
35. Korner P, Bobick A, Oddie C, Friberg P. Sympathoadrenal system is critical for structural change in genetic hypertension. Hypertension 1993; 22:243-252.